| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 6e-07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |